APAC Healthcare Weekly (December 21)–Fosun Pharma, Hansoh, Daiichi Sankyo, Takeda, Hanmi, Max Health
Fosun Pharma is acquiring 53% stake in Green Valley. Hansoh inked exclusive license agreement with Glenmark Pharma. Daiichi Sankyo’s Enhertu got...
336 Views
Hong Kong Single Stock Options Weekly (Dec 15–19): Fragile Internals Meet Depressed Impiled Vols
Weak breadth and softer prices defined the week as single stock implied vols drifted toward historically low levels, creating a more fragile...
218 Views
Primer: Zhong Ao Home (1538 HK) - Dec 2025
Zhong Ao Home is a small, independent property management company in China facing a challenging market, characterized by stagnant revenue and...
350 Views
Primer: New World Development (17 HK) - Dec 2025
New World Development (NWD) is a high-leverage property developer currently trading at a significant discount to its book value, positioning it...
376 Views
InSilico Medicine (英矽智能) IPO: AI Assets as Upside
InSilico Medicine launches IPO in Hong Kong to raise $293 million, with valuation anchored by innovative assets and potential upside from AI...
507 Views